RareResearch.AI
← Back to atlas

L543F

Category 4 — Stable Fold, Function DisruptedLikely pathogenicTransmembrane · predictedEditorial
LeucinePhenylalanine at position 543 · TM7 (529-549), helical transmembrane · WFS1 (Wolframin)

Leucine → Phenylalanine at position 543 inside TM7. ClinVar Likely pathogenic for Wolfram syndrome 1. AlphaMissense 0.303 (below threshold) — AM under-call. DynaMut2 ΔΔG -1.34 kcal/mol (destabilising). Same position as L543P (Atlas card adjacent) but with aromatic introduction.

Interactive 3D Structure

Wild-type reference
Wild-type L543 — hydrogen bond to M539
Fullscreen ↗
DynaMut2 mutant · L543F
Mutant F543 — polar contact to I547 lost (4 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

4 lost5 gained11 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondM539M539Preserved
Hydrogen bondV546V546Preserved
Hydrogen bondI547I547Preserved
Polar contactM539M539Preserved
Polar contactC541C541Preserved
Polar contactV545Gained
Polar contactV546V546Preserved
Polar contactI547I547Preserved
Aromatic / πF881Gained
Van der WaalsV545Gained
Van der WaalsI547Lost
HydrophobicF354Lost
HydrophobicM357M357Preserved
HydrophobicV412Gained
HydrophobicV415V415Preserved
HydrophobicI416Gained
HydrophobicT436T436Preserved
HydrophobicW540Lost
HydrophobicI547Lost
HydrophobicF881F881Preserved

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-1.34kcal/mol
Destabilising — moderate
AlphaMissense
0.303
LBen
AlphaFold pLDDT
91
model confidence
Schema
Cat 4
Category 4 — Stable Fold, Function Disrupted

Clinical Evidence

ClinVar classificationLikely pathogenic
Review statuscriteria provided, single submitter
Associated conditionsWolfram syndrome 1
InheritanceWolfram syndrome 1 (AR) documented.
Population frequency (gnomAD v4)Ultra-rare · AF 0.000068%
cDNA changec.1627C>T
ClinVar accessionVCV002499486
Last evaluated2023/03/01 00:00

Observed at very low frequency in gnomAD.

Structural Context

Position 543 sits in TM7. Same neighbor environment as L543P: GLU542 (2.5 Å), SER544 (2.5 Å), MET539 (3.7 Å), TRP540 (3.9 Å), PHE881 (4.1 Å — TM7-TM11 cross-helix).

Replacing L543 with phenylalanine adds aromatic volume to the TM7 mid-helix. Unlike L543P which introduces a backbone kink, L543F preserves α-helical structure but creates a tandem aromatic motif with W540 nearby. The TM7-TM11 cross-helix contact to F881 now involves two phenylalanines in TM7 (F543, with W540 aromatic neighbor) interacting with F881 across the interface.

The |ΔΔG| of 1.34 reflects meaningful fold cost. AlphaMissense's 0.303 below threshold is AM under-call; ClinVar Pathogenic + Wolfram 1 establishes pathogenicity.

Amino-acid chemistry
Leucine (L) → Phenylalanine (F) — branched aliphatic hydrophobic replaced by aromatic hydrophobic.
Position in the protein
TM7 (residues 529–549) · position 543 mid-helix, bilayer-embedded (pLDDT 91).

Druggability Assessment

Category 3/4 — Most Druggable (AM under-call). |ΔΔG| = 1.34 — fold survives at meaningful cost. AlphaMissense 0.303 below threshold but ClinVar Pathogenic + Wolfram 1.

Mechanism is aromatic volume mismatch in TM7 plus rearrangement of TM7-TM11 cross-helix contact. Therapeutic strategy: same TM7-TM11 interface as L543P.

Why this matters

L543F + L543P at the same position, different chemistries, both pathogenic — position 543 is a multi-substitution hotspot in TM7.
Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the L543F PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download L543F PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.

UniProt Domain Annotation

Chain1890 · Wolframin
Transmembrane529549 · Helical